Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
81 hedge funds and large institutions have $135M invested in Immunomedics Inc in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
7% more funds holding
Funds holding: 76 → 81 (+5)
0% less capital invested
Capital invested by funds: $135M → $135M (-$360K)
15% less call options, than puts
Call options by funds: $3.26M | Put options by funds: $3.85M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$383K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$338K |
| 3 |
Goldman Sachs
New York
|
+$241K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$240K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$236K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.65M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$668K |
| 3 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$548K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$365K |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
-$148K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JFA
76
JNBA Financial Advisors
Bloomington,
Minnesota
| $5K | – | – | – |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| $1K | -$767 | -227 | -62% |
|
|
MI
78
Markston International
White Plains,
New York
| $1K | – | – | – |
|
|
TCM
79
Tradewinds Capital Management
Bellingham,
Washington
| $1K | – | – | – |
|
80
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $213 | +$1.94K | +573 | +1% |
|
|
CIA
81
Capital Impact Advisors
Boston,
Massachusetts
| $161 | – | – | – |
|
|
RCM
82
RA Capital Management
Boston,
Massachusetts
| – | -$3.65M | -1,000,000 | Closed |
|
|
83
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$548K | -150,000 | Closed |
|
|
84
Allianz Asset Management
Munich,
Germany
| – | -$365K | -100,000 | Closed |
|
85
Prudential Financial
Newark,
New Jersey
| – | -$51K | -14,045 | Closed |
|
|
BKBG
86
BHF Kleinwort Benson Group
Brussels,
Belgium
| – | -$34K | -13,000 | Closed |
|
|
VFA
87
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$26K | -7,055 | Closed |
|
88
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$7K | -1,840 | Closed |
|
IMMU Hedge Fund Activity: Q3 2014 in Review
81 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2014, worth a combined $135M — down 0.27% from $135M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IMMU positions and 7 closed out — a net gain of 5 holders — while 25 added to existing stakes and 20 trimmed.
The largest buyer was Vanguard Group, adding an estimated $383K. The largest seller was RA Capital Management, exiting entirely with an estimated $3.65M sold.
- 81 institutional investors held Immunomedics Inc (IMMU) as of Q3 2014, up from 76 in Q2 2014.
- Funds reported $135M of Immunomedics Inc stock for Q3 2014, down 0.27% quarter-over-quarter.
- 12 funds opened new Immunomedics Inc positions in Q3 2014 and 7 closed out, a net change of +5 holders.
- The largest Immunomedics Inc buyer in Q3 2014 was Vanguard Group, an estimated $383K added.
- The largest Immunomedics Inc seller in Q3 2014 was RA Capital Management, an estimated $3.65M sold.
Based on aggregated 13F filings for Q3 2014.